NCT06799247Phase 3Active not recruiting

Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

Study sponsor: Cartesian Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-12-30Estimated
Enrollment · participants128Actual
Source updated2026-09-01Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 100 participants (planned). After: 128 participants (actual).

Primary completion date changed

Before: 30 Nov 2026. After: 30 Dec 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview